Kurinji Pandiyan
Chief Strategy & Operations OfficerDr. Kurinji Pandiyan, Ph.D., is Chief Strategy & Operations Officer of ImageneBio, Inc. from 2025. Most recently, Dr. Pandiyan served on the Executive Committee of Poseida Therapeutics, Inc. (now part of the Roche–Genentech Group) as Head of Portfolio & Strategy and Chief of Staff to the CEO, where she orchestrated the autoimmune disease development plan that culminated in a successful acquisition. Prior to Poseida, Dr. Pandiyan held leadership roles in Corporate Development and Global Commercial Strategy, as well as program leadership, at Atara Biotherapeutics. She also led program strategy and execution for dermatology programs at AVITA Medical. Earlier in her career, she served as a Principal at the Boston Consulting Group (BCG), where she advised numerous biopharma companies on commercial and R&D strategy, corporate development, as well as organizational effectiveness and transformation. Dr. Pandiyan holds a Ph.D. in Human Genetics & Molecular Biology from the Johns Hopkins School of Medicine.
Positions
- Company NameImageneBio, Inc.Stock CodeIMAPositionChief Strategy & Operations OfficerColleagues
- KYKristin YaremaCEO & Director
- JJJonathan Jian WangChairman
- YGYanina Grant-HuertaCFO, Principal Financial Officer & Principal Accounting Officer
- RSRenuka SivendranChief Technical Officer
- MRMatt RobbinsGeneral Counsel
- DBDavid BonitaLead Independent Director
- OSOtello StampacchiaIndependent Director
- JPJoseph P. SlatteryDirector
